Stevanato Group/STVN

$26.73

-5.88%
-
1D1W1MYTD1YMAX

About Stevanato Group

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

Ticker

STVN

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Franco Stevanato

Employees

5,635

Headquarters

Piombino dese, Italy

Stevanato Group Metrics

BasicAdvanced
$8.57B
Market cap
48.58
P/E ratio
$0.58
EPS
-
Beta
$0.06
Dividend rate
0.2%
Dividend yield
$8.57B
$36.30
$23.00
360.59K
$0.06
1.501
1.056
22.529
35.018
9.82%
19.74%
7.81%
13.68%
10.81%
48.579
7.422
6.237
7.661
0.2%
0.2%
10.34%
1.79%
17.91%
27.35%

What the Analysts think about Stevanato Group

Analyst Ratings

Majority rating from 9 analysts.
Buy

Price Targets

Average projection from 8 analysts.
28.62% upside
High $38.00
Low $29.99
$26.73
Current price
$34.38
Average price target

Stevanato Group Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
14.09% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
€320.6M
18.13%
Net income
€45.2M
19.58%
Profit margin
14.09%
1.22%

Stevanato Group Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 6.68%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
€0.11
€0.14
€0.15
€0.18
-
Expected
€0.12
€0.13
€0.15
€0.19
€0.11
Surprise
-7.95%
7.59%
-1.64%
-6.68%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Stevanato Group stock?

Stevanato Group (STVN) has a market cap of $8.57B as of April 21, 2024.

What is the P/E ratio for Stevanato Group stock?

The price to earnings (P/E) ratio for Stevanato Group (STVN) stock is 48.58 as of April 21, 2024.

Does Stevanato Group stock pay dividends?

Yes, the Stevanato Group (STVN) stock pays dividends to shareholders. As of April 21, 2024, the dividend rate is $0.05747 and the yield is 0.2%. Stevanato Group has a payout ratio of 9.82% on a trailing twelve-month basis.

When is the next Stevanato Group dividend payment date?

The next Stevanato Group (STVN) dividend payment date is unconfirmed.

What is the beta indicator for Stevanato Group?

Stevanato Group (STVN) does not currently have a Beta indicator.

What is the Stevanato Group stock price target?

The target price for Stevanato Group (STVN) stock is $34.38, which is 28.62% above the current price of $26.73. This is an average based on projections from 8 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Stevanato Group stock

Buy or sell Stevanato Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing